Hello, Guest
Login
Sign Up
 
 

Stocks Review: ENSCO PLC (NYSE:ESV), the Goodyear Tire & Rubber Company (NASDAQ:GT), Keryx Biopharmaceuticals (NASDAQ:KERX)

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 03/05/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

ENSCO PLC (NYSE:ESV) shares fell 2.33% and closed at $58.32 in the last trading session after ESV’s stock had its target price trimmed by Barclays Capital from $79.00 to $75.00 in a report issued last week. They currently have an overweight rating on the stock.

Additionally, the company, on Feb. 20, reported diluted earnings per share from continuing operations of $1.04 in fourth quarter 2012, as compared to $0.97 per share in fourth quarter 2011. Earnings from discontinued operations in fourth quarter 2011 were $0.02 per share. Diluted earnings per share were $0.94 in fourth quarter 2012, compared to $0.99 in fourth quarter 2011.

How Should Investors Trade ESV After The Recent Movement? Find Out Here

The Goodyear Tire & Rubber Company (NASDAQ:GT) shares decreased 2.24% and closed at $12.67 in the last trading session. The company, on Feb. 21, said that it has priced its offering of $900 million aggregate principal amount of 8-year senior notes. The offering was increased from a previously announced offering size of $750 million. The notes are senior unsecured obligations of the company. They will be sold at 100% of the principal amount and will bear interest at a rate of 6.5%. Goodyear expects the offering to close on February 25. The company plans to use the net proceeds from the offering to fund discretionary contributions to its frozen U.S. pension plans and, to the extent not used for such purposes, for general corporate purposes.

Is GT Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Keryx Biopharmaceuticals (NASDAQ:KERX) shares fell 2.23% and closed at $7.03. The company, on Feb. 22, announced that Ron Bentsur, the Company’s Chief Executive Officer, was scheduled to present at the Citigroup 2013 Global Healthcare Conference, being held February 25-27, 2013, in New York City. Mr. Bentsur’s presentation is scheduled to take place on Wednesday, February 27th, at 2:15 PM ET.

Is KERX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.